In this single institution study, the authors screened biorepository materials obtained from patients undergoing resection for early stage cancer. They wished to identify serum markers related to early recurrence. A 7-component panel was developed that had a negative predictive value of 83% and an accuracy of 78%. The accuracy was 70%.
You are here:
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters
Submitted by: Mark Ferguson
Source: The Annals of Thoracic Surgery
Keywords:
Author(s): Christopher W. Seder, Andrew T. Arndt, Lia Jordano, Sanjib Basu, Cristina L. Fhied, Selina Sayidine, Gary W. Chmielewski, Kelsey Gallo, Michael J. Liptay, Jeffrey A. Borgia
